Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549


FORM 10-Q



x

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934

 

 

 

For the Quarterly Period Ended March 30, 2003

 

or

 

 

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934

 

 

 

For the transition period from ___________ to ___________

 

 

 

Commission file number 0-5260

 

 

 

REMEDYTEMP, INC.
(Exact name of registrant as specified in its charter)

 

California

 

95-2890471

(State or other jurisdiction of Incorporation or organization)

 

(I.R.S.  Employer Identification Number)

 

 

 

101 Enterprise

 

 

Aliso Viejo, California

 

92656

(Address of principal executive offices)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code: (949) 425-7600



          Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes   x

No   o

          As of May 9, 2003 there were 8,474,970 shares of Class A Common Stock and 1,197,950 shares of Class B Common Stock outstanding.



Table of Contents

RemedyTemp, Inc.

INDEX

 

 

 

Page No.

 

 

 


PART I–– FINANCIAL INFORMATION

 

 

 

 

Item 1.  Financial Statements

 

 

 

 

 

 

Consolidated Balance Sheets as of March 30, 2003 (unaudited) and September 29, 2002

3

 

 

 

 

 

 

Consolidated Statements of Income for the three fiscal months and six fiscal months ended March 30, 2003 and March 31, 2002 (unaudited)

4

 

 

 

 

 

 

Consolidated Statements of Cash Flows for the six fiscal months ended March 30, 2003 and March 31, 2002 (unaudited)

5

 

 

 

 

 

 

Condensed Notes to Consolidated Financial Statements (unaudited)

6

 

 

 

 

 

Item 2.  Management’s Discussion and Analysis of Consolidated Financial Condition and Results of Operations

10

 

 

 

 

Item 3.  Quantitative and Qualitative Disclosure About Market Risk

18

 

 

 

 

Item 4.  Controls and Procedures

18

 

 

 

PART II–– OTHER INFORMATION

 

 

 

 

Item 1.  Legal Proceedings

19

 

 

 

 

Item 2.  Changes In Securities and Use of Proceeds

*

 

 

 

 

Item 3.  Defaults Upon Senior Securities

*

 

 

 

 

Item 4.  Submission of Matters to a Vote of Security Holders

20

 

 

 

 

Item 5.  Other Information

*

 

 

 

 

Item 6.  Exhibits and Reports on Form 8-K

21

 

 

 

SIGNATURES

23

 

 

CERTIFICATIONS

24

* No information provided due to inapplicability of item.

2


Table of Contents

RemedyTemp, Inc.

PART I—FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

CONSOLIDATED BALANCE SHEETS
(amounts in thousands, except per share amounts)

 

 

March 30,
2003
(unaudited)

 

September 29,
2002

 

 


 


ASSETS

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

28,049

 

$

26,101

Investments

 

 

26,920

 

 

23,021

Accounts receivable, net of allowance for doubtful accounts of $2,235 and $1,913, respectively

 

 

53,006

 

 

61,724

Prepaid expenses and other current assets

 

 

3,515

 

 

5,745

Deferred and current income taxes

 

 

12,423

 

 

7,486

 

 



 



Total current assets

 

 

123,913

 

 

124,077

Fixed assets, net

 

 

15,058

 

 

16,268

Other assets

 

 

1,843

 

 

2,035

Intangible assets, net of accumulated amortization of $80 and $24, respectively

 

 

1,795

 

 

10

Goodwill

 

 

2,173

 

 

4,283

 

 



 



Total Assets

 

$

144,782

 

$

146,673

 

 



 



LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

956

 

$

3,151

Accrued workers’ compensation (Note 5)

 

 

26,480

 

 

20,135

Accrued payroll, benefits and related costs

 

 

13,431

 

 

13,787

Accrued licensees’ share of gross profit

 

 

2,262

 

 

2,866

Other accrued expenses

 

 

2,635

 

 

3,621

 

 



 



Total current liabilities

 

 

45,764

 

 

43,560

Deferred income taxes

 

 

90

 

 

90

 

 



 



Total liabilities

 

 

45,854

 

 

43,650

Commitments and contingent liabilities

 

 

 

 

 

 

Shareholders’ equity (Note 6):

 

 

 

 

 

 

Preferred Stock, $.01 par value; authorized 5,000 shares; none outstanding

 

 

—  

 

 

—  

Class A Common Stock, $.01 par value; authorized 50,000 shares; 8,469 and 8,142 issued and outstanding at March 30, 2003 and  September 29, 2002, respectively

 

 

85

 

 

82

Class B Non-Voting Common Stock, $.01 par value; authorized 4,530 shares; 1,198 and 1,253 issued and outstanding at March 30, 2003 and September 29, 2002, respectively

 

 

12

 

 

13

Additional paid-in capital

 

 

42,807

 

 

39,923

Unearned compensation

 

 

(6,926

)

 

(4,728

Retained earnings

 

 

62,950

 

 

67,733

 

 



 



Total shareholders’ equity

 

 

98,928

 

 

103,023

 

 



 



Total Liabilities and Shareholders’ Equity

 

$

144,782

 

$

146,673

 

 



 




See accompanying notes to consolidated financial statements.

3


Table of Contents

RemedyTemp, Inc.

CONSOLIDATED STATEMENTS OF INCOME
(amounts in thousands, except per share amounts)

(unaudited)

 

 

Three Months Ended

 

Six Months Ended

 

 

 


 


 

 

 

March 30,
2003

 

March 31,
2002

 

March 30,
2003

 

March 31,
2002

 

 

 



 



 



 



 

Direct sales

 

$

73,300

 

$

66,846

 

$

143,568

 

$

129,633

 

Licensed franchise sales

 

 

42,183

 

 

39,247

 

 

92,133

 

 

90,751

 

Franchise royalties

 

 

346

 

 

475

 

 

916

 

 

938

 

Initial franchise fees

 

 

6

 

 

—  

 

 

12

 

 

6

 

 

 



 



 



 



 

Total revenues

 

 

115,835

 

 

106,568

 

 

236,629

 

 

221,328

 

Cost of direct sales

 

 

64,777

 

 

54,788

 

 

122,558

 

 

105,338

 

Cost of licensed franchise sales

 

 

33,605

 

 

30,362

 

 

73,492

 

 

70,155

 

Licensees’ share of gross profit

 

 

5,640

 

 

5,975

 

 

12,361

 

 

13,984

 

Selling and administrative expenses

 

 

16,369

 

 

14,264

 

 

31,514

 

 

28,759

 

Depreciation and amortization

 

 

1,299

 

 

1,308

 

 

2,508

 

 

2,715

 

 

 



 



 



 



 

(Loss) income from operations

 

 

(5,855

)

 

(129

)

 

(5,804

)

 

377

 

Other income:

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income, net

 

 

63

 

 

161

 

 

402

 

 

400

 

Other, net

 

 

228

 

 

212

 

 

377

 

 

485

 

 

 



 



 



 



 

(Loss) income before income taxes

 

 

(5,564

)

 

244

 

 

(5,025

)

 

1,262

 

(Benefit from) provision for income taxes

 

 

(2,752

)

 

53

 

 

(2,663

)

 

379

 

 

 



 



 



 



 

(Loss) income before cumulative effect of adoption of a new accounting standard

 

 

(2,812

)

 

191

 

 

(2,362

)

 

883

 

Cumulative effect of adoption of a new accounting standard, net of income taxes of $1,634

 

 

––  

 

 

––  

 

 

(2,421

)

 

––  

 

 

 



 



 



 



 

Net (loss) income

 

$

(2,812

)

$

191

 

$

(4,783

)

$

883

 

 

 



 



 



 



 

Earnings per share – basic and diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

(Loss) income before cumulative effect of adoption of a new accounting standard

 

$

(0.31

)

$

0.02

 

$

(0.26

)

$

0.10

 

Cumulative effect of adoption of a new accounting standard, net of incomes taxes

 

 

––  

 

 

––  

 

 

(0.27

)

 

––  

 

 

 



 



 



 



 

Net (loss) income – basic and diluted

 

$

(0.31

)

$

0.02

 

$

(0.53

)

$

0.10

 

 

 



 



 



 



 

See accompanying notes to consolidated financial statements.

4


Table of Contents

RemedyTemp, Inc.

CONSOLIDATED STATEMENTS OF CASH FLOWS
(amounts in thousands)

(unaudited)

 

 

Six Months Ended

 

 

 


 

 

 

March 30,
2003

 

March 31,
2002

 

 

 



 



 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net (loss) income

 

$

(4,783

)

$

883

 

Adjustments to reconcile net (loss) income to net cash provided by operating activities:

 

 

 

 

 

 

 

Cumulative effect of adoption of a new accounting standard, net of income taxes

 

 

2,421

 

 

––  

 

Depreciation and amortization

 

 

2,508

 

 

2,715

 

Provision for losses on accounts receivable

 

 

759

 

 

734

 

Restricted stock compensation expense

 

 

635

 

 

307

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

Trading investments

 

 

(622

)

 

(447

)

Accounts receivable

 

 

7,959

 

 

8,599

 

Prepaid expenses and other current assets

 

 

2,230

 

 

(224

)

Other assets

 

 

192

 

 

801

 

Accounts payable

 

 

(2,195

)

 

(816

)

Accrued workers’ compensation

 

 

6,345

 

 

4,637

 

Accrued payroll, benefits and related costs

 

 

(356

)

 

(1,216

)

Accrued licensees’ share of gross profit

 

 

(604

)

 

(731

)

Other accrued expenses

 

 

(986

)

 

(164

)

Deferred and current income taxes

 

 

(3,303

)

 

(1,748

)

 

 



 



 

Net cash provided by operating activities

 

 

10,200

 

 

13,330